Genocea Biosciences Inc (NASDAQ:GNCA) announced its quarterly earnings data on Thursday. The company reported ($0.37) EPS for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.40) by $0.03, Market Beat Ratings reports. Several analysts have recently commented on the stock. Needham & Company LLC decreased their price objective on shares of Genocea Biosciences from […]
